Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori

CompletedOBSERVATIONAL
Enrollment

670

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Helicobacter Pylori; Eradication Rate
Interventions
OTHER

PPI regimen

All patients received PPI regimen( lansoprazole or esomeprazole,bismuth amoxicillin,clarithromycin for14 days). Demographic data,treatment regimens, outcomes of therapy, adherence to therapy and adverse event were retrieved.

OTHER

P-CAB regimen

All patients received P-CAB regimen(vonoprazan,bismuth ,amoxicillin,clarithromycin for14 days). Demographic data,treatment regimens, outcomes of therapy, adherence to therapy and adverse event were retrieved.

Trial Locations (1)

250012

Qilu hosipital, Jinan

All Listed Sponsors
lead

Shandong University

OTHER

NCT05301725 - Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori | Biotech Hunter | Biotech Hunter